Market cap
$286,067 Mln
Revenue (TTM)
$62,168 Mln
P/E Ratio
26.1
P/B Ratio
5.5
Div. Yield
1.8 %
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
286,067 | 2,342 | 89,343 | 42,458 | 25,776 |
Revenue ($ Mln) |
62,168 | 57,194 | 123,005 | 27,878 | 17,959 |
Net Profit ($ Mln) |
10,988.49 | -6,140.89 | 11,316.00 | 151.08 | 2,029.00 |
Net Margin (%) |
17.68 | -10.74 | 9.20 | 0.54 | 11.30 |
RoE (%) |
22.20 | -6.68 | 13.00 | -- | 16.92 |
Price to Earnings |
26.09 | -- | 7.96 | -- | 12.50 |
Price-To-Book |
5.53 | 0.43 | 0.95 | 92.95 | 1.99 |
Income Statement ($ Mln)
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
62,168.16 | 57,193.68 | 123,005.00 | 27,878.43 | 17,959.00 |
|
Cost of Revenue
|
12,379.20 | 35,073.21 | 37,093.00 | 20,974.61 | 11,834.00 |
|
Gross Profit
|
48,106.00 | 22,483.42 | 88,756.00 | 5,799.18 | 5,782.00 |
|
Operating Expenses
|
35,080.26 | 16,227.69 | 67,811.00 | 5,900.57 | 5,050.00 |
|
Operating Profit (EBIT)
|
14,708.69 | 5,892.78 | 18,101.00 | 1,003.26 | 4,123.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
13,247.29 | -236.74 | 13,950.00 | 745.73 | 2,762.00 |
|
Provision for Tax
|
2,254.79 | 5,470.65 | 3,073.00 | 292.27 | 687.00 |
|
Profit after Tax (Net Income)
|
10,988.49 | -6,140.89 | 11,316.00 | 151.08 | 2,029.00 |
|
Minority Interest
|
-4.00 | -435.78 | 438.00 | -302.38 | -46.00 |
|
Consolidated Profit
|
2,326.00 | -8,030.06 | 0.00 | -247.16 | 0.00 |
Liabilities ($ Mln)
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
51,636.49 | 101,935.38 | 92,529.00 | 456.82 | 12,466.00 |
|
Minority Interest
|
-4.00 | -435.78 | 438.00 | -302.38 | -46.00 |
|
Non-Current Liabilities
|
36,775.83 | 93,265.25 | 134,382.00 | 11,724.29 | 8,093.00 |
|
Current Liabilities
|
31,211.69 | 31,727.83 | 30,719.00 | 14,984.26 | 2,429.00 |
|
Total Liabilities
|
114,074.00 | 229,262.20 | 272,631.00 | 22,912.53 | 23,195.00 |
Assets ($ Mln)
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
88,317.49 | 170,675.23 | 232,545.00 | 13,638.66 | 13,891.00 |
|
Current Assets
|
31,392.37 | 66,014.50 | 25,223.00 | 14,257.24 | 9,202.00 |
|
Total Assets
|
114,074.00 | 229,262.20 | 272,631.00 | 22,912.53 | 23,195.00 |
|
Total Debt*
|
34,130.52 | 88,317.86 | 87,366.00 | 11,905.18 | 7,579.00 |
|
Net Current Assets
|
181.00 | 34,286.70 | -5,496.00 | -727.02 | 6,773.00 |
Cashflow ($ Mln)
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
14,575.00 | 23,195.21 | 33,643.00 | 1,395.32 | 3,324.00 |
|
Cash Flow from Investing Activities
|
-6,808.00 | -16,624.48 | -16,157.00 | -1,226.45 | -537.00 |
|
Cash from Financing Activities
|
-7,544.00 | -16,321.25 | -14,346.00 | 406.51 | -1,755.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.74 | -4.63 | 13.40 | 4.42 | 11.82 |
|
ROE (%)
|
22.20 | -6.68 | 13.00 | 26.35 | 16.92 |
|
ROA (%)
|
7.34 | -2.31 | 3.81 | 0.39 | 8.00 |
|
EBIT Margin (%)
|
24.07 | 13.28 | 14.78 | 4.01 | 21.36 |
|
Net Margin (%)
|
17.68 | -10.74 | 9.20 | 0.54 | 11.30 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
6.95 | -3.97 | -0.25 | 13.47 | 9.01 |
|
EBIT Growth (%)
|
14.31 | 342.36 | -42.33 | -8.66 | 21.24 |
|
Net Profit Growth (%)
|
16.91 | 44.06 | -49.94 | -83.20 | -0.29 |
|
EPS Growth (%)
|
16.91 | 31.92 | -47.51 | -89.01 | 6.26 |
|
Book Value Growth (%)
|
12.60 | -13.61 | -0.11 | -78.89 | 8.56 |
Valuation Ratios
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
14.00 | -0.15 | 5.43 | 67.64 | 10.43 |
|
Price / Book Value
|
2.95 | 0.01 | 1.12 | 18.44 | 1.97 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
8.45 | 1.91 | 4.52 | 18.56 | 7.32 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.51 | 0.75 | 0.91 | 17.27 | 0.53 |
|
Short term debt to equity ratio
|
0.10 | 0.06 | 0.04 | 4.07 | 0.00 |
|
Current Ratio
|
1.01 | 2.08 | 0.82 | 0.95 | 3.79 |
|
Quick Ratio
|
0.79 | 2.06 | 0.82 | 0.95 | 3.50 |
|
Interest Coverage
|
8.48 | 0.96 | 4.29 | 3.00 | 8.46 |
Operating Efficiency Ratios
| AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Comcast Corporation Class A (CMCSA) | Live Nation Entertainment (LYV) | Fox Corporation Class B (FOX) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
26.30 | 11.28 | 11.01 | 11.80 | 20.36 |
|
Asset Turnover
|
0.42 | 0.22 | 0.41 | 0.71 | 0.71 |
|
Receivable days
|
82.12 | 73.28 | 40.64 | 27.75 | 54.18 |
|
Inventory Days
|
203.44 | 3.03 | -- | 1.00 | 18.37 |
|
Payable days
|
496.71 | 130.16 | 116.93 | 38.16 | 30.44 |
|
Cash Conversion Cycle
|
-211.15 | -53.86 | -- | -9.41 | 42.12 |